Trial Profile
Effects of Infliximab Treatment on QoL Outcomes (Depression, Anxiety and Sleep Disorders) in Patients with Ankylosing Spondylitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 02 Sep 2015 New trial record